Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RG7800 hydrochloride is an orally active modulator of SMN2 splicing.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 1,055 | 待询 | ||
10 mg | ¥ 1,650 | 待询 | ||
50 mg | ¥ 5,645 | 待询 | ||
100 mg | ¥ 8,450 | 待询 | ||
200 mg | 待询 | 待询 | ||
500 mg | 待询 | 待询 |
RG7800 hydrochloride (1449598-06-4 free base) 的其他形式现货产品:
产品描述 | RG7800 hydrochloride is an orally active modulator of SMN2 splicing. |
靶点活性 | SMN2 splicing: 87 nM , SMN protein:, EC1.5x: 23 nM |
体外活性 | RG7800 hydrochloride is an orally active modulator of SMN2 splicing(EC1.5xs of 23 nM and 87 nM for SMN2 splicing and SMN protein).RG7800 hydrochloride is the first small molecule SMN2 splicing modifier to enter human clinical trials. |
体内活性 | RG7800 dose-dependently elevates the SMN protein level in the brain and in peripheral tissue of Δ7 mice. RG7800 is a favorable agent metabolism and pharmacokinetic (DMPK) profile in the rat and in cynomolgus monkey with good oral bioavailability. |
别名 | RO6885247 hydrochloride, RG7800 hydrochloride |
分子量 | N/A |
分子式 | C24H28N6O.xHCl |
CAS No. | T12718 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 113.5 mg/mL
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RG7800 hydrochloride (1449598-06-4 free base) T12718 Others RO6885247 Hydrochloride RO6885247 hydrochloride 1449598-06-4 RG 7800 Hydrochloride 1449598-06-4 free base RG7800 hydrochloride (1449598064 free base) RG7800 hydrochloride RO-6885247 Hydrochloride RG7800 hydrochloride (1449598 06 4 free base) RG-7800 Hydrochloride RG-7800 hydrochloride (1449598-06-4 free base) RO 6885247 Hydrochloride RG7800 Hydrochloride Inhibitor inhibitor inhibit